The civic record
Read. Follow. Verify.Congressional Hearing on Saccharin Ban Moratorium (1977)
Record date · July 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This document is a transcript record of a 1977 House subcommittee hearing regarding proposed legislation to delay a government ban on the artificial sweetener saccharin. The bills under discussion aim to pause the ban for 18 months while the National Academy of Sciences conducts a comprehensive review of food additive safety and risk-benefit analysis.
The hearing addresses whether the federal government should continue to allow the sale of saccharin in food and drugs while scientific studies on its potential cancer risks are evaluated.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Food and Drug Manufacturers
These entities are affected by the legal status of saccharin as a permitted or banned additive in their products.
Consumers
Consumers are affected by the availability of products containing saccharin and the regulatory determination of its safety.
Key Facts
- The hearing was held on June 27, 1977, by the Subcommittee on Health and the Environment.
- H.R. 7753 proposes an 18-month moratorium on the ban of saccharin as a food, drug, and cosmetic additive.
- The legislation directs the Institute of Medicine to conduct a one-year review of the toxicity and carcinogenicity of food additives.
- The review is tasked with determining if animal cancer studies can accurately predict human health effects.
Show all 7 facts
- The review is tasked with determining if regulatory decisions should weigh the risks and benefits of food additives.
- H.R. 5166 proposes amending the Federal Food, Drug, and Cosmetic Act to authorize risk-benefit evaluations for food additives.
- The bills seek to allow the continued marketing of saccharin until the scientific evaluation is completed.
Frequently Asked Questions
What is the purpose of these bills?
Who would conduct the safety review?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Risk-Benefit Analysis Debate
The hearing highlights a pivotal moment in regulatory history where Congress considered mandating risk-benefit analysis for food additives rather than relying solely on toxicity findings.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy75Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools
